vs

Side-by-side financial comparison of ENNIS, INC. (EBF) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $100.2M, roughly 2.0× ENNIS, INC.). ENNIS, INC. runs the higher net margin — 10.8% vs 6.7%, a 4.1% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 0.4%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $15.7M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 1.4%).

ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

EBF vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
2.0× larger
RGEN
$197.9M
$100.2M
EBF
Growing faster (revenue YoY)
RGEN
RGEN
+13.2% gap
RGEN
13.6%
0.4%
EBF
Higher net margin
EBF
EBF
4.1% more per $
EBF
10.8%
6.7%
RGEN
More free cash flow
RGEN
RGEN
$1.8M more FCF
RGEN
$17.6M
$15.7M
EBF
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
1.4%
EBF

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
EBF
EBF
RGEN
RGEN
Revenue
$100.2M
$197.9M
Net Profit
$10.8M
$13.3M
Gross Margin
31.9%
52.5%
Operating Margin
15.0%
9.0%
Net Margin
10.8%
6.7%
Revenue YoY
0.4%
13.6%
Net Profit YoY
6.1%
143.9%
EPS (diluted)
$0.42
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EBF
EBF
RGEN
RGEN
Q4 25
$100.2M
$197.9M
Q3 25
$98.7M
$188.8M
Q2 25
$97.2M
$182.4M
Q1 25
$92.7M
$169.2M
Q4 24
$99.8M
$174.1M
Q3 24
$99.0M
$154.9M
Q2 24
$103.1M
$154.1M
Q1 24
$97.4M
$151.3M
Net Profit
EBF
EBF
RGEN
RGEN
Q4 25
$10.8M
$13.3M
Q3 25
$13.2M
$14.9M
Q2 25
$9.8M
$14.9M
Q1 25
$9.0M
$5.8M
Q4 24
$10.2M
$-30.3M
Q3 24
$10.3M
$-654.0K
Q2 24
$10.7M
$3.3M
Q1 24
$10.1M
$2.1M
Gross Margin
EBF
EBF
RGEN
RGEN
Q4 25
31.9%
52.5%
Q3 25
30.5%
53.2%
Q2 25
31.1%
50.0%
Q1 25
29.5%
53.6%
Q4 24
29.3%
26.1%
Q3 24
30.1%
50.0%
Q2 24
30.0%
49.8%
Q1 24
28.4%
49.5%
Operating Margin
EBF
EBF
RGEN
RGEN
Q4 25
15.0%
9.0%
Q3 25
12.5%
8.9%
Q2 25
13.7%
7.6%
Q1 25
13.0%
3.9%
Q4 24
13.1%
-17.7%
Q3 24
13.3%
-5.1%
Q2 24
13.3%
1.0%
Q1 24
13.3%
1.3%
Net Margin
EBF
EBF
RGEN
RGEN
Q4 25
10.8%
6.7%
Q3 25
13.3%
7.9%
Q2 25
10.1%
8.2%
Q1 25
9.7%
3.4%
Q4 24
10.2%
-17.4%
Q3 24
10.4%
-0.4%
Q2 24
10.4%
2.2%
Q1 24
10.4%
1.4%
EPS (diluted)
EBF
EBF
RGEN
RGEN
Q4 25
$0.42
$0.24
Q3 25
$0.51
$0.26
Q2 25
$0.38
$0.26
Q1 25
$0.34
$0.10
Q4 24
$0.39
$-0.55
Q3 24
$0.40
$-0.01
Q2 24
$0.41
$0.06
Q1 24
$0.39
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EBF
EBF
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$31.3M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$304.8M
$2.1B
Total Assets
$354.3M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EBF
EBF
RGEN
RGEN
Q4 25
$31.3M
$767.6M
Q3 25
$31.9M
$748.7M
Q2 25
$32.6M
$708.9M
Q1 25
$72.5M
$697.2M
Q4 24
$68.6M
$757.4M
Q3 24
$122.6M
$784.0M
Q2 24
$123.7M
$809.1M
Q1 24
$110.9M
$780.6M
Total Debt
EBF
EBF
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EBF
EBF
RGEN
RGEN
Q4 25
$304.8M
$2.1B
Q3 25
$305.4M
$2.1B
Q2 25
$301.2M
$2.1B
Q1 25
$302.0M
$2.0B
Q4 24
$297.7M
$2.0B
Q3 24
$358.4M
$2.0B
Q2 24
$354.4M
$2.0B
Q1 24
$349.8M
$2.0B
Total Assets
EBF
EBF
RGEN
RGEN
Q4 25
$354.3M
$2.9B
Q3 25
$361.8M
$2.9B
Q2 25
$361.7M
$2.9B
Q1 25
$348.9M
$2.9B
Q4 24
$346.1M
$2.8B
Q3 24
$406.8M
$2.8B
Q2 24
$406.2M
$2.9B
Q1 24
$399.2M
$2.8B
Debt / Equity
EBF
EBF
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EBF
EBF
RGEN
RGEN
Operating Cash FlowLast quarter
$16.4M
$25.7M
Free Cash FlowOCF − Capex
$15.7M
$17.6M
FCF MarginFCF / Revenue
15.7%
8.9%
Capex IntensityCapex / Revenue
0.7%
4.1%
Cash ConversionOCF / Net Profit
1.52×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$42.5M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EBF
EBF
RGEN
RGEN
Q4 25
$16.4M
$25.7M
Q3 25
$10.5M
$48.1M
Q2 25
$8.0M
$28.6M
Q1 25
$12.8M
$15.0M
Q4 24
$18.2M
$39.2M
Q3 24
$11.8M
$49.3M
Q2 24
$23.1M
$42.2M
Q1 24
$16.6M
$44.7M
Free Cash Flow
EBF
EBF
RGEN
RGEN
Q4 25
$15.7M
$17.6M
Q3 25
$9.0M
$43.4M
Q2 25
$6.6M
$21.5M
Q1 25
$11.1M
$11.4M
Q4 24
$17.5M
$33.6M
Q3 24
$10.7M
$42.3M
Q2 24
$20.6M
$37.4M
Q1 24
$15.0M
$36.4M
FCF Margin
EBF
EBF
RGEN
RGEN
Q4 25
15.7%
8.9%
Q3 25
9.2%
23.0%
Q2 25
6.8%
11.8%
Q1 25
12.0%
6.8%
Q4 24
17.6%
19.3%
Q3 24
10.8%
27.3%
Q2 24
20.0%
24.3%
Q1 24
15.3%
24.0%
Capex Intensity
EBF
EBF
RGEN
RGEN
Q4 25
0.7%
4.1%
Q3 25
1.4%
2.5%
Q2 25
1.4%
3.9%
Q1 25
1.8%
2.1%
Q4 24
0.6%
3.2%
Q3 24
1.1%
4.5%
Q2 24
2.4%
3.1%
Q1 24
1.7%
5.5%
Cash Conversion
EBF
EBF
RGEN
RGEN
Q4 25
1.52×
1.93×
Q3 25
0.80×
3.23×
Q2 25
0.81×
1.92×
Q1 25
1.41×
2.57×
Q4 24
1.78×
Q3 24
1.15×
Q2 24
2.16×
12.70×
Q1 24
1.63×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons